Foundation for Innovative New Diagn

Published purpose

This project builds on Canada’s funding to the Foundation for Innovative New Diagnostics (FIND) during COVID-19. The initial project aims at accelerate the roll-out of safe, affordable, and effective COVID-19 diagnostics in Low- and Lower-Middle Income Countries. This project supports FIND in using testing technologies developed during COVID-19 to expand the range of diseases detected with a single test. This includes other respiratory diseases, sexually transmitted infections, and Human papillomavirus (HPV)-based screening for cervical cancer. The project aims to increase testing for the most marginalized, including women, children, and vulnerable groups. Project activities include: (1) supporting the development of more straightforward sample collection methods, including self-sampling; and (2) conducting in-country customer preference surveys and barrier-to-access surveys to guide the final development and introduction of tests.